Ms. Kwon has been with MTS Health Partners since 2008 and is focused on Life Sciences, primarily working on strategic advisory and financing assignments for therapeutics companies. She has experience working with companies in biotech, specialty pharmaceuticals, generics, and medical devices. She is based in San Francisco.

Prior to joining MTS Health Partners, Ms. Kwon developed a well-rounded perspective across various roles on Wall Street. Before MTS, she was a Principal in the Healthcare Equity Capital Markets Group at Bank of America, where she originated and executed public equity financing transactions, such as IPOs and follow-ons. Before Bank of America, Ms. Kwon was a public life sciences investor at Merlin Biomed Asset Management, a healthcare hedge fund. Prior to that, she was a Senior Research Analyst at UBS, publishing on companies in the Specialty Pharmaceuticals space. Prior to business school, she worked at the Equinox Group, a healthcare market research and consulting firm, focused on market assessments (incorporating healthcare provider, patient, and payor research) and new product forecasting for multi-national biopharma and device companies.

Ms. Kwon has an MBA from the Graduate School of Business at Columbia University and a BA from Tufts University.